Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy

被引：0
|
作者：
Li, Qiang [1 ,2 ]
Yang, Zhihuan [1 ,2 ]
Fang, Kuo [1 ,2 ]
Wei, Shuning [1 ,2 ]
Sun, Jiali [1 ,2 ]
Liu, Wei [1 ,2 ]
Chen, Xiaojuan [1 ,2 ]
Huang, Wenyang [1 ,2 ]
Zhang, Guangji [1 ,2 ]
Shi, Yin [1 ,2 ]
Liu, Yuntao [1 ,2 ]
Gong, Xiaoyuan [1 ,2 ]
Liu, Fang [1 ,2 ]
Zhou, Xueli [1 ,2 ]
Wang, Jianxiang [1 ,2 ]
Wang, Ying [1 ,2 ,3 ,4 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin Key Lab Cell Therapy Blood Dis, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China
来源：
BLOOD SCIENCE | 2023年 / 5卷 / 01期
关键词：
D O I：
10.1097/BS9.0000000000000137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：62 / 65
页数：4
相关论文
共 50 条
  • [41] Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
    Kuipers, Maria T.
    Spanjaart, Anne M.
    Bonifazi, Francesca
    diBlasi, Roberta
    Zinzani, Pier L.
    Thieblemont, Catherine
    Baudet, Mathilde
    Biemond, Bart J.
    Kok, Wouter E. M.
    Kersten, Marie J.
    LEUKEMIA & LYMPHOMA, 2024, 65 (03) : 399 - 402
  • [42] Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients
    Laurent, Elisabeth
    Sieber, Anna
    Salzer, Benjamin
    Wachernig, Anna
    Seigner, Jacqueline
    Lehner, Manfred
    Geyeregger, Rene
    Kratzer, Bernhard
    Jager, Ulrich
    Kunert, Renate
    Pickl, Winfried F.
    Traxlmayr, Michael W.
    ACS SYNTHETIC BIOLOGY, 2021, 10 (05): : 1184 - 1198
  • [43] Profiling the Peripheral Blood Immune Cell Repertoire in Large-B Cell Lymphoma Patients Treated with CD19 CAR-T
    Cheloni, Giulia
    Kanata, Eleni
    Stroopinsky, Dina
    Karagkouni, Dimitra
    Liegel, Jessica J.
    Torres, Daniela
    Hauser, Joshua
    Bindal, Poorva
    Koshy, Anita G.
    Pita-Juarez, Yered
    Bot, Adrian
    Mattie, Mike
    Chou, Justin
    Rosenblatt, Jacalyn
    Avigan, David
    Vlachos, Ioannis
    BLOOD, 2021, 138
  • [44] Patterns and Safety of Glucocorticosteroids Use Following CD19 CAR-T Cell Therapy for B- Cell Lymphoma
    Luttwak, Efrat
    Flynn, Jessica R.
    Devlin, Sean M.
    Cassanello, Giulio
    Corona, Magdalena
    Dahi, Parastoo B.
    De Abia, Alejandro Luna
    Fein, Joshua
    Giralt, Sergio A.
    Landego, Ivan
    Lin, Richard J.
    Palomba, Maria Lia
    Parascondola, Allison
    Park, Jae H.
    Saldia, Amethyst
    Scordo, Michael
    Tomas, Ana Alarcon
    Shah, Gunjan L.
    Perales, Miguel-Angel
    Salles, Gilles
    Shouval, Roni
    BLOOD, 2023, 142
  • [45] Continuous B cell destruction and regeneration is crucial for effective response to anti CD19 CAR-T cell therapy
    Nevo, Neta
    Milman, Neta
    Cooper, Tim J.
    Zuckerman, Tsila
    Shen-Orr, Shai S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 761 - 761
  • [46] Single-Cell Transcriptomic Analysis of Myeloid Lineage Evolution from CD19 CAR-T Cell Therapy
    Cui, Yajuan
    Wang, Peilong
    Zhu, Hongkai
    Wang, Zhihua
    Zhang, Huifang
    Xu, Haodong
    Li, Ruijuan
    Sheng, Yue
    Peng, Hongling
    PATHOBIOLOGY, 2025, : 1 - 7
  • [47] CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report
    Sun, Yao
    Su, Yongfeng
    Wang, Yizhi
    Liu, Na
    Li, Yuhang
    Chen, Jianlin
    Qiao, Zhuoqing
    Niu, Jingwen
    Hu, Jiangwei
    Zhang, Bin
    Ning, Hongmei
    Hu, Liangding
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
    Walker, Bryan
    Zimmer, Andrea J.
    Stohs, Erica J.
    Lunning, Matthew
    Lyden, Elizabeth
    Abbas, Anum
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [49] Should CD19 CAR-T Cells for ALL be Followed by Allogeneic Stem Cell
    Ramos, Carlos A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 1 - 2
  • [50] Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
    Kong, Delin
    Yang, Tingting
    Geng, Jia
    Jing, Ruirui
    Zhang, Qiqi
    Wei, Guoqing
    Huang, He
    Hu, Yongxian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 876 - 880
12345